Healthcare provider profile · identity verified

Jeanine Phan, D.O.

Family Practice · SAN JOSE, CA · NPI 1083994487

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	608	204
Amlodipine Besylate	Amlodipine Besylate	374	140
Sertraline Hcl	Sertraline Hcl	330	117
Losartan Potassium	Losartan Potassium	327	118
Levothyroxine Sodium	Levothyroxine Sodium	320	103
Memantine Hcl	Memantine Hcl	309	102
Trazodone Hcl	Trazodone Hcl	296	110
Lisinopril	Lisinopril	279	99
Donepezil Hcl	Donepezil Hcl	248	92
Gabapentin	Gabapentin	227	79
Furosemide	Furosemide	224	90
Quetiapine Fumarate	Quetiapine Fumarate	164	54
Tamsulosin Hcl	Tamsulosin Hcl	164	59
Atenolol	Atenolol	156	51
Metoprolol Succinate	Metoprolol Succinate	155	51
Simvastatin	Simvastatin	153	56
Famotidine	Famotidine	152	67
Alendronate Sodium	Alendronate Sodium	144	52
Fluticasone Propionate	Fluticasone Propionate	135	69
Metoprolol Tartrate	Metoprolol Tartrate	134	51
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	120	36
Albuterol Sulfate Hfa	Albuterol Sulfate	119	57
Omeprazole	Omeprazole	115	36
Lovastatin	Lovastatin	112	36
Metformin Hcl Er	Metformin Hcl	102	39
Pantoprazole Sodium	Pantoprazole Sodium	102	27
Mirtazapine	Mirtazapine	101	35
Cefadroxil	Cefadroxil	98	74
Triamcinolone Acetonide	Triamcinolone Acetonide	96	44
Spiriva Respimat	Tiotropium Bromide	93	28
Hydralazine Hcl	Hydralazine Hcl	92	35
Alvesco	Ciclesonide	88	30
Metformin Hcl	Metformin Hcl	85	34
Pradaxa	Dabigatran Etexilate Mesylate	74	28
Venlafaxine Hcl Er	Venlafaxine Hcl	74	21
Allopurinol	Allopurinol	73	23
Finasteride	Finasteride	73	23
Clopidogrel	Clopidogrel Bisulfate	68	25
Tizanidine Hcl	Tizanidine Hcl	63	17
Glipizide	Glipizide	57	21
Pravastatin Sodium	Pravastatin Sodium	56	18
Wixela Inhub	Fluticasone Propion/Salmeterol	56	27
Isosorbide Mononitrate Er	Isosorbide Mononitrate	53	15
Trospium Chloride	Trospium Chloride	52	21
Potassium Chloride	Potassium Chloride	51	21
Prednisone	Prednisone	50	30
Jardiance	Empagliflozin	48	17
Fluoxetine Hcl	Fluoxetine Hcl	45	16
Olanzapine	Olanzapine	45	suppressed
Ozempic	Semaglutide	45	suppressed
Duloxetine Hcl	Duloxetine Hcl	44	12
Escitalopram Oxalate	Escitalopram Oxalate	43	11
Hydrochlorothiazide	Hydrochlorothiazide	43	15
Propranolol Hcl	Propranolol Hcl	42	15
Divalproex Sodium	Divalproex Sodium	40	13
Doxycycline Monohydrate	Doxycycline Monohydrate	39	32
Glipizide Er	Glipizide	39	12
Nystatin	Nystatin	39	22
Carvedilol	Carvedilol	37	13
Insulin Glargine-Yfgn	Insulin Glargine-Yfgn	34	13
Montelukast Sodium	Montelukast Sodium	34	13
Hydrocortisone	Hydrocortisone	33	16
Terazosin Hcl	Terazosin Hcl	33	suppressed
Myrbetriq	Mirabegron	30	suppressed
Humulin N Kwikpen	Insulin Nph Human Isophane	29	suppressed
Olanzapine Odt	Olanzapine	29	suppressed
Spironolactone	Spironolactone	29	suppressed
Rosuvastatin Calcium	Rosuvastatin Calcium	28	14
Buspirone Hcl	Buspirone Hcl	26	11
Citalopram Hbr	Citalopram Hydrobromide	25	suppressed
Estradiol	Estradiol	25	11
Fluocinonide	Fluocinonide	25	13
Humulin N	Insulin Nph Human Isophane	25	11
Lorazepam	Lorazepam	25	suppressed
Combivent Respimat	Ipratropium/Albuterol Sulfate	22	11
Xarelto	Rivaroxaban	22	suppressed
Humulin R	Insulin Regular, Human	21	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	21	suppressed
Rivastigmine	Rivastigmine	21	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	20	19
Hydromorphone Hcl	Hydromorphone Hcl	19	suppressed
Lactulose	Lactulose	19	suppressed
Meloxicam	Meloxicam	19	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	18	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	18	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	18	suppressed
Midodrine Hcl	Midodrine Hcl	18	suppressed
Veo Insulin Syringe	Syringe-Needle,insulin,0.5 Ml	18	suppressed
Chlorthalidone	Chlorthalidone	17	suppressed
Cholestyramine	Cholestyramine (With Sugar)	17	suppressed
Ondansetron Hcl	Ondansetron Hcl	17	suppressed
Tramadol Hcl	Tramadol Hcl	17	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	17	suppressed
Amiodarone Hcl	Amiodarone Hcl	16	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	16	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	16	15
Valproic Acid	Valproic Acid (As Sodium Salt)	16	suppressed
Warfarin Sodium	Warfarin Sodium	16	suppressed
Advair Hfa	Fluticasone Propion/Salmeterol	15	suppressed
Baclofen	Baclofen	15	suppressed
Latanoprost	Latanoprost	15	suppressed
Oxycodone Hcl	Oxycodone Hcl	15	suppressed
Bupropion Hcl Sr	Bupropion Hcl	14	suppressed
Flunisolide	Flunisolide	14	suppressed
Ondansetron Odt	Ondansetron	14	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	13	11
Clonidine	Clonidine	13	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	13	suppressed
Eliquis	Apixaban	13	suppressed
Ipratropium Bromide	Ipratropium Bromide	13	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	13	suppressed
Methenamine Hippurate	Methenamine Hippurate	13	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	13	suppressed
Bupropion Xl	Bupropion Hcl	12	suppressed
Metronidazole	Metronidazole	12	suppressed
Mupirocin	Mupirocin	12	suppressed
Ropinirole Hcl	Ropinirole Hcl	12	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	12	suppressed
Amoxicillin	Amoxicillin	11	suppressed
Naproxen	Naproxen	11	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	11	suppressed
Paroxetine Hcl	Paroxetine Hcl	11	suppressed
Terbinafine Hcl	Terbinafine Hcl	11	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	11	suppressed
Verapamil Er	Verapamil Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error